Entrada Therapeutics Inc. (TRDA)
NASDAQ · Healthcare
Entrada Therapeutics Inc. PE Ratio 2021–2026
Current and historical P/E ratio for Entrada Therapeutics Inc. (TRDA), calculated by dividing the latest closing price by the trailing twelve-month earnings per share (EPS). As of March 31, 2025 it is 6.19.
From: 03/31/2023To: 03/31/2026
Stock Price
TTM Net EPS
PE Ratio
Entrada Therapeutics Inc. PE Ratio — FAQ
Entrada Therapeutics Inc. (TRDA) pe ratio over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TRDA's pe ratio history?
The chart and table above show Entrada Therapeutics Inc.'s pe ratio by year and by quarter, including the growth rate.